Diagnostic and staging impact of radiotherapy planning FDG-PET-CT in non-small-cell lung cancer

Radiotherapy and Oncology

Volumn 101, Issue 2, 2011, Pages 284-290

  Lin, Peter ^a   Koh, Eng Siew ^a,b   Lin, Michael ^a   Vinod, Shalini K ^a   Ho Shon, Ivan ^a   Yap, June ^a   Som, Seu ^a  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

18F fluorodeoxyglucose; FDG; Non small cell lung cancer; PET CT; Radiotherapy planning; Staging PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE COURSE; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; PRIORITY JOURNAL; RADIATION RESPONSE; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TREATMENT OUTCOME; TUMOR BURDEN; WHOLE BODY IMAGING;

EID: 81755161519     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.06.030     Document Type: Article

References (30)

1. B.A. Dwamena, S.S. Sonnad, and J.O. Angobaldo Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT Radiology 213 1999 530 536 (Pubitemid 29510603)
2. 18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer J Nucl Med 42 2001 1596 1604 (Pubitemid 33131317)
3. J.T. Annema, O.S. Hoekstra, and E.F. Smit Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA Lung Cancer 44 2004 53 60 (Pubitemid 38324606)
4. C. Greco, K. Rosenzweig, and G.L. Cascini Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC) Lung Cancer 7 2007 125 134 (Pubitemid 47043188)
5. D. De Ruysscher, and C.M. Kirsch PET scans in radiotherapy planning of lung cancer Radiother Oncol 96 2010 335 338
6. D. De Ruysscher, S. Wanders, and H.E. Van Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study Int J Radiat Oncol Biol Phys 62 2005 988 994 (Pubitemid 40884408)
7. U. Nestle, A. Schaefer-Schuler, and S. Kremp Target volume definition for (18)F-FDG PET positive lymph nodes in radiotherapy of patients with non-small cell lung cancer Eur J Nucl Med Mol Imaging 34 2006 453 462
8. J.S. Belderbos, W.D. Heemsbergen, and J.K. De Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 66 2006 126 134 (Pubitemid 44175671)
9. M. MacManus, U. Nestle, and K.E. Rosenzweig Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
10. 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer J Nucl Med 46 2005 1342 1348 (Pubitemid 43733485)
11. I.S. Grills, D. Yan, and Q.C. Black Clinical implications of defining the gross tumor volume with combination of CT and (18)FDG-positron emission tomography in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 67 2007 709 719 (Pubitemid 46215884)
12. A. Grgic, U. Nestle, and A. Schaefer-Schuler FDG-PET based radiotherapy planning in lung cancer: optimum breathing protocol and patient positioning-an intraindividual comparison Int J Radiat Oncol Biol Phys 73 2009 103 111
13. S. Everitt, A. Herschtal, and J. Callahan High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer Cancer 116 2010 5030 5037
14. L.H. Sobin, and C. Wittekind International Union Against Cancer (UICC), TNM Classification of Malignant Tumours 6th ed. 2002 Wiley-Liss New York 99 103
15. C.F. Mountain, and C.M. Dressler Regional lymph node classification for lung cancer staging Chest 111 1997 1718 1723 (Pubitemid 27260108)
16. NHS executive: The National Cancer Plan A plan for investment, a plan for reform 2000 Department of Health London
17. National institute for clinical excellence: The Diagnosis and Treatment of Lung Cancer. London: National Institute for Clinical Excellence; 2005.
18. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
19. S.C. Huang Anatomy of SUV. Standardised uptake value Nucl Med Biol 27 2000 643 646
20. J.F. Vansteenkiste, S.G. Stroobants, and P.J. Dupont Prognostic importance of the standardized uptake value on FDG PET in NSCLC: An analysis of 125 cases J Clin Oncol 17 1999 3201 3206
21. P. Giraud, M. Antoine, and A. Larrouy Evaluation on microscopic tumour extension in non-small cell lung cancer for three-dimensional conformal radiotherapy planning Int J Radiat Oncol Biol Phys 48 2000 1015 1024
22. I. Grills, D. Fitch, and N.S. Goldstein Clinicpathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy Int J Radiat Oncol Biol Phys 67 2007 727 734
23. M. Baumann, D. Zips, and S. Appold Radiotherapy of lung cancer: Technology meets biology meets multidisciplinarity Radiother Oncol 91 2009 279 281
24. A. Abramyuk, S. Tokalov, and K. Zöphel Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer? Radiother Oncol 91 2009 399 404
25. J.W.L. Hugo, A.P. Lambin, and D. De Ruysscher FDG for dose painting: A rational choice Radiother Oncol 97 2010 163 164
26. A.T. Fernandes, J. Shen, and J. Finlay Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes Radiother Oncol 95 2010 178 184
27. 18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group Eur J Cancer 35 1999 1773 1782 (Pubitemid 29512308)
28. 18F-FDG PET/CT J Nucl Med 45 2004 56S 65S
29. T.M. Blodgett, B.M. McCook, and M.P. Federle Positron emission tomography/computed tomography: protocol issues and options Semin Nucl Med 36 2006 157 168 (Pubitemid 43320451)
30. A.V. Taira, R.J. Herfkens, and S.S. Gambhir Detection of bone metastases: assessment of integrated FDG PET/CT imaging Radiology 243 2007 204 211 (Pubitemid 46579712)